rs35131433

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_000722.4(CACNA2D1):​c.3134A>C​(p.Asp1045Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0052 in 1,610,030 control chromosomes in the GnomAD database, including 38 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D1045N) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0036 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0054 ( 36 hom. )

Consequence

CACNA2D1
NM_000722.4 missense

Scores

1
7
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 5.63

Publications

13 publications found
Variant links:
Genes affected
CACNA2D1 (HGNC:1399): (calcium voltage-gated channel auxiliary subunit alpha2delta 1) The preproprotein encoded by this gene is cleaved into multiple chains that comprise the alpha-2 and delta subunits of the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. Mutations in this gene can cause cardiac deficiencies, including Brugada syndrome and short QT syndrome. Alternate splicing results in multiple transcript variants, some of which may lack the delta subunit portion. [provided by RefSeq, Nov 2014]
CACNA2D1 Gene-Disease associations (from GenCC):
  • short QT syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • developmental and epileptic encephalopathy 110
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000722.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009257674).
BP6
Variant 7-81959300-T-G is Benign according to our data. Variant chr7-81959300-T-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 263797.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 AR,Unknown,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000722.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D1
NM_000722.4
MANE Select
c.3134A>Cp.Asp1045Ala
missense
Exon 38 of 39NP_000713.2P54289-2
CACNA2D1
NM_001366867.1
c.3170A>Cp.Asp1057Ala
missense
Exon 38 of 39NP_001353796.1P54289-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D1
ENST00000356860.8
TSL:1 MANE Select
c.3134A>Cp.Asp1045Ala
missense
Exon 38 of 39ENSP00000349320.3P54289-2
CACNA2D1
ENST00000443883.2
TSL:5
c.3170A>Cp.Asp1057Ala
missense
Exon 38 of 39ENSP00000409374.2H0Y715
CACNA2D1
ENST00000957014.1
c.3155A>Cp.Asp1052Ala
missense
Exon 38 of 39ENSP00000627073.1

Frequencies

GnomAD3 genomes
AF:
0.00362
AC:
550
AN:
152052
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00123
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00151
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00680
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00299
AC:
749
AN:
250800
AF XY:
0.00306
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.000869
Gnomad ASJ exome
AF:
0.000497
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00162
Gnomad NFE exome
AF:
0.00550
Gnomad OTH exome
AF:
0.00344
GnomAD4 exome
AF:
0.00536
AC:
7821
AN:
1457860
Hom.:
36
Cov.:
28
AF XY:
0.00521
AC XY:
3778
AN XY:
725500
show subpopulations
African (AFR)
AF:
0.00102
AC:
34
AN:
33396
American (AMR)
AF:
0.000784
AC:
35
AN:
44666
Ashkenazi Jewish (ASJ)
AF:
0.000307
AC:
8
AN:
26078
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39648
South Asian (SAS)
AF:
0.000429
AC:
37
AN:
86194
European-Finnish (FIN)
AF:
0.00137
AC:
73
AN:
53374
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5758
European-Non Finnish (NFE)
AF:
0.00670
AC:
7428
AN:
1108514
Other (OTH)
AF:
0.00339
AC:
204
AN:
60232
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
333
667
1000
1334
1667
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
278
556
834
1112
1390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00361
AC:
550
AN:
152170
Hom.:
2
Cov.:
32
AF XY:
0.00323
AC XY:
240
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.00123
AC:
51
AN:
41574
American (AMR)
AF:
0.00118
AC:
18
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3462
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
0.00151
AC:
16
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00680
AC:
462
AN:
67966
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
29
57
86
114
143
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00509
Hom.:
10
Bravo
AF:
0.00339
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00568
EpiControl
AF:
0.00510

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
3
not provided (3)
-
-
1
Brugada syndrome (1)
-
-
1
Cardiovascular phenotype (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Uncertain
-0.070
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.25
T
Eigen
Uncertain
0.21
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.73
T
M_CAP
Benign
0.027
D
MetaRNN
Benign
0.0093
T
MetaSVM
Benign
-0.78
T
MutationAssessor
Benign
1.6
L
PhyloP100
5.6
PrimateAI
Uncertain
0.55
T
PROVEAN
Uncertain
-2.6
D
REVEL
Benign
0.25
Sift
Benign
0.11
T
Sift4G
Benign
0.18
T
Varity_R
0.33
gMVP
0.84
Mutation Taster
=62/38
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs35131433;
hg19: chr7-81588616;
COSMIC: COSV99070867;
COSMIC: COSV99070867;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.